Fidelity Investments’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $25.4K | Sell |
1,294
-2,229
| -63% | -$54.5K | ﹤0.01% | 4420 |
|
|
2025
Q4 | $94.3K | Sell |
3,523
-2,949
| -46% | -$76K | ﹤0.01% | 3781 |
|
|
2025
Q3 | $172K | Sell |
6,472
-731
| -10% | -$18.9K | ﹤0.01% | 3416 |
|
|
2025
Q2 | $165K | Buy |
7,203
+2,397
| +50% | +$59.5K | ﹤0.01% | 3388 |
|
|
2025
Q1 | $139K | Sell |
4,806
-16,539
| -77% | -$528K | ﹤0.01% | 3410 |
|
|
2024
Q4 | $793K | Sell |
21,345
-12,990
| -38% | -$594K | ﹤0.01% | 2756 |
|
|
2024
Q3 | $1.67M | Buy |
34,335
+6,583
| +24% | +$289K | ﹤0.01% | 2452 |
|
|
2024
Q2 | $1.11M | Buy |
27,752
+6,866
| +33% | +$285K | ﹤0.01% | 2490 |
|
|
2024
Q1 | $917K | Buy |
20,886
+1,481
| +8% | +$76.5K | ﹤0.01% | 2530 |
|
|
2023
Q4 | $1.2M | Sell |
19,405
-7,417
| -28% | -$390K | ﹤0.01% | 2418 |
|
|
2023
Q3 | $1.23M | Sell |
26,822
-3,394
| -11% | -$185K | ﹤0.01% | 2401 |
|
|
2023
Q2 | $1.74M | Buy |
30,216
+61
| +0.2% | +$2.7K | ﹤0.01% | 2359 |
|
|
2023
Q1 | $1.13M | Buy |
30,155
+847
| +3% | +$27.8K | ﹤0.01% | 2499 |
|
|
2022
Q4 | $821K | Buy |
29,308
+32
| +0.1% | +$929 | ﹤0.01% | 2585 |
|
|
2022
Q3 | $823K | Sell |
29,276
-231
| -0.8% | -$7.54K | ﹤0.01% | 2655 |
|
|
2022
Q2 | $1.03M | Sell |
29,507
-118
| -0.4% | -$4.21K | ﹤0.01% | 2665 |
|
|
2022
Q1 | $1.06M | Buy |
+29,625
| New | +$840K | ﹤0.01% | 2776 |
|
|
2021
Q3 | – | Sell |
-125
| Closed | -$3K | – | 4286 |
|
|
2021
Q2 | $3K | Hold |
125
| – | – | ﹤0.01% | 3818 |
|
|
2021
Q1 | $2K | Buy |
+125
| New | +$2.32K | ﹤0.01% | 3693 |
|
|
2020
Q4 | – | Sell |
-50
| Closed | -$1K | – | 3797 |
|
|
2020
Q3 | $1K | Buy |
+50
| New | +$1.01K | ﹤0.01% | 3525 |
|
|
2020
Q2 | – | Sell |
-7
| Closed | – | – | 3551 |
|
|
2020
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 3589 |
|
|
2019
Q4 | $0 | Sell |
7
-42
| -86% | -$806 | ﹤0.01% | 3751 |
|
|
2019
Q3 | $1K | Buy |
+49
| New | +$1.02K | ﹤0.01% | 3612 |
|
|
2019
Q2 | – | Sell |
-150
| Closed | -$3K | – | 3710 |
|
|
2019
Q1 | $3K | Buy |
+150
| New | +$3.36K | ﹤0.01% | 3341 |
|
|
2018
Q1 | – | Sell |
-148,408
| Closed | -$2.85M | – | 2658 |
|
|
2017
Q4 | $2.85M | Buy |
+148,408
| New | +$2.77M | ﹤0.01% | 2289 |
|
|
2017
Q2 | – | Sell |
-303,257
| Closed | -$4.4M | – | 2616 |
|
|
2017
Q1 | $4.4M | Sell |
303,257
-1,014,284
| -77% | -$15.9M | ﹤0.01% | 2200 |
|
|
2016
Q4 | $24.3M | Sell |
1,317,541
-710,086
| -35% | -$13.8M | ﹤0.01% | 1604 |
|
|
2016
Q3 | $38.5M | Sell |
2,027,627
-370,904
| -15% | -$6.73M | 0.01% | 1414 |
|
|
2016
Q2 | $38.7M | Sell |
2,398,531
-89,630
| -4% | -$1.26M | 0.01% | 1385 |
|
|
2016
Q1 | $29.9M | Buy |
2,488,161
+386,205
| +18% | +$4.55M | ﹤0.01% | 1478 |
|
|
2015
Q4 | $29.9M | Sell |
2,101,956
-53,346
| -2% | -$705K | ﹤0.01% | 1481 |
|
|
2015
Q3 | $25.2M | Buy |
2,155,302
+292,141
| +16% | +$4.38M | ﹤0.01% | 1563 |
|
|
2015
Q2 | $32.8M | Buy |
1,863,161
+1,763,161
| +1,763% | +$27.5M | ﹤0.01% | 1528 |
|
|
2015
Q1 | $1.5M | Hold |
100,000
| – | – | ﹤0.01% | 2463 |
|
|
2014
Q4 | $1.16M | Hold |
100,000
| – | – | ﹤0.01% | 2522 |
|
|
2014
Q3 | $1.17M | Buy |
+100,000
| New | +$1.04M | ﹤0.01% | 2518 |
|
Other funds holding AMPH
VCM
BTW
Fidelity Investments's AMPH Position: Q1 2026 in Review
Fidelity Investments reduced its Amphastar Pharmaceuticals (AMPH) stake by 63% in Q1 2026, selling an estimated $54.5K and leaving 1,294 shares worth $25.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4420.
Fidelity Investments first reported a position in AMPH in Q3 2014 and has held it in 36 quarters since. The position peaked at $38.7M in Q2 2016. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.
- Fidelity Investments held 1,294 shares of Amphastar Pharmaceuticals worth $25.4K as of Q1 2026.
- Fidelity Investments sold 2,229 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $54.5K.
- Amphastar Pharmaceuticals made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4420 holding.
- Fidelity Investments first reported a position in Amphastar Pharmaceuticals in Q3 2014 and has held it in 36 quarters since.
- Fidelity Investments's Amphastar Pharmaceuticals position peaked at $38.7M in Q2 2016.
- 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.